Categories
News

A toy maker takes his case against Trump’s tariffs to the Supreme Court

(Reuters) Within days of Donald Trump announcing his sweeping “Liberation Day” tariffs in April, Rick Woldenberg was looking for a law firm to help him sue the U.S. president.

“I’m not willing to allow politicians to destroy what we have built up over generations,” said Woldenberg, CEO of educational toy company Learning Resources, a family business in the Chicago suburbs founded by his mother.

Woldenberg, along with attorneys at the Akin Gump firm, will be at the U.S. Supreme Court on Wednesday to attempt to secure a historic victory. The nine justices will be hearing arguments in the case called Learning Resources v. Trump, along with two related cases in which plaintiffs also argue that the Republican president’s tariffs are unlawful.

One of the related cases was filed by Oregon and other Democratic-led states. The other was brought by the Liberty Justice Center, a libertarian nonprofit, on behalf of five small businesses, including a wine distributor called V.O.S. Selections and another educational toy company called MicroKits.

While the court typically takes months to issue rulings after hearing arguments, the Trump administration has asked it to act swiftly in this case.

LARGE COMPANIES ON THE SIDELINES

Large U.S. companies have stayed on the sidelines of the tariffs litigation. They did not bring lawsuits and have not filed amicus – or friend-of-the-court – briefs offering their views. Such briefs are commonly used by companies to highlight the importance of cases brought by other litigants.

By contrast, about a dozen small businesses have agreed to serve as plaintiffs in a batch of separate lawsuits brought by nonprofits challenging the tariffs that are still playing out in lower courts, in addition to the businesses involved in the Supreme Court litigation. And another 700 signed onto an amicus brief filed by We Pay The Tariffs, an advocacy group, against Trump’s action.

Trump’s tariffs have hit small- and medium-sized businesses particularly hard because they “don’t have the same flexibility as large companies to manage the impact,” said John Horn, a professor at the Olin Business School at Washington University in St. Louis.

Large companies have more cash on hand, Horn said, so they were better able to stock up on inventory before the tariffs took effect. They can also better manage prices and supply chains, Horn added. One reason large companies are not suing to challenge Trump’s tariffs is that they are more focused on lobbying efforts, Horn said.

“Large businesses have the flexibility of lobbying the government for exemptions,” Horn said. “Small businesses don’t have that.”

Woldenberg said his legal bills have been in the millions of dollars, but he felt suing was a necessary cost.

“This is certainly not for everyone,” Woldenberg said of his legal advocacy. “Hundreds of thousands of businesses in the United States are similarly situated to ours, but to my knowledge I’m the only person in the United States – a country of 300 million people – who has chosen to sue on their own resources.”

‘CAN’T PLAN AHEAD’

At issue before the Supreme Court on Wednesday are tariffs Trump imposed using the International Emergency Economic Powers Act of 1977, or IEEPA. These tariffs thus far have netted about $100 billion for U.S. coffers. This law was meant for use during national emergencies. Trump deemed the U.S. trade deficit a national emergency even though the United States has run trade deficits every year since 1975.

On April 2, as part of his “Liberation Day” announcement, Trump imposed a baseline tariff of 10% on virtually all countries, with higher tariffs – anywhere from 11% to 50% – on dozens of countries.

The lawsuits before the Supreme Court argue that Congress did not intend for IEEPA to authorize presidents to impose tariffs. Three lower courts have ruled against Trump’s tariffs, saying they exceeded his lawful authority under IEEPA.

The IEEPA tariffs are paid by U.S. importers like Learning Resources, which manufactures most of its educational toys in Asia.

In his inauguration speech in January, Trump said tariffs will allow the United States to become a “manufacturing nation once again.” Importers have said they want to move manufacturing to the United States, but the parts and services they need are unavailable or prohibitively expensive.

CUTTING BACK

In response to Trump’s tariffs, Learning Resources cut back expansion plans to keep more cash on hand, Woldenberg said.

Woldenberg canceled a building project that would have added 600,000 square feet (55,700 square meters) of warehouse and office space for the 500 employees of Learning Resources and a related toy company, hand2mind, that he runs. Woldenberg also abandoned plans to hire about 30 more employees in 2025, and cut back on other expenditures like marketing and training for workers.

When Trump’s tariffs hit, “I predicted we’d be smaller and make less money,” Woldenberg said. “And both of those things are true.”

Woldenberg’s frustrations are shared by David Levi, founder of MicroKits, a smaller toy company in Charlottesville, Virginia, that serves as a plaintiff in the parallel case at the Supreme Court.

MicroKits sells electronic instruments, including a synthesizer called the Synth-a-Sette that teaches children about conductivity. Levi imports small electronic parts, mostly from China, then assembles his products in Virginia along with the help of a part-time employee.

Levi said that, when Trump’s tariffs on Chinese imports spiked above 100% this spring, he temporarily stopped importing and slowed down production so he would still have work for his part-time employee. Levi reduced the employee’s weekly schedule from 25 hours to 15 hours, and assembled thousands of fewer toys than anticipated.

MicroKits, which Levi founded in 2020 after working at large toy companies Hasbro and Mattel, was growing 30% a year and was aiming to hit $1 million in revenue in 2025. Instead, because of the tariffs, revenue will be around $400,000 this year.

Levi said consumer-grade electrical clips he needs for his products are not being manufactured in the United States in any meaningful way. Domestically made clips are designed for aerospace and medical uses and would cost at least 10 times more than consumer-grade ones from Asia, Levi said.

Levi expected to pay tariffs and other taxes when he founded MicroKits, but was not prepared for the constant uncertainty caused by the Trump administration adjusting tariff rates with little public notice.

“In a world where tariffs can go above 100% and then back down again, you’re just trying to guess what happens next and can’t plan ahead,” Levi said.

‘OVERWHELMING RESPONSE’

Levi said he came across a webpage where Liberty Justice Center was encouraging businesses to join its lawsuit. The public interest law firm is representing him and four other businesses at no cost.

“After we issued a public call for plaintiffs, we received an overwhelming response from small businesses nationwide,” said Jeffrey Schwab, a lawyer at Liberty Justice Center. “Our team spoke with dozens of owners and selected five whose experiences best illustrate the broad harms caused by the tariffs and who were prepared to accept the responsibilities and public attention of litigation.”

Victor Schwartz is the founder and president of Manhattan-based wine distributor V.O.S. Selections, one of those five.

Schwartz said he felt a “moral imperative” to challenge Trump’s tariffs, which he said have cost his company about $200,000. The tariffs have hit wine importers particularly hard as they contend with inflation, a weakening dollar and declining U.S. alcohol consumption.

“I was shocked that those with much more power and money did not step up,” Schwartz said.

Categories
News

Fed has discretion to deny crypto bank’s master account, panel says

(Westlaw) A federal appeals court has affirmed the Federal Reserve’s discretion to deny a master account to a Wyoming-chartered crypto bank that had argued federal law mandates access to the nation’s central banking system.

Custodia Bank Inc. v. Federal Reserve Board of Governors et al., No. 24-8024, 2025 WL 3039669 (10th Cir. Oct. 31, 2025).

A 2-1 panel of the 10th U.S. Circuit Court of Appeals on Oct. 31 ruled that while Custodia Bank Inc. was eligible for a master account, the Federal Reserve Bank of Kansas City was not statutorily required to grant one.

Writing for the majority, U.S. Circuit Judge David M. Ebel said the discretionary language of the Federal Reserve Act of 1913, 12 U.S.C.A. a7 342, controls.

He said Congress did not override that discretion when it passed the Monetary Control Act of 1980, 12 U.S.C.A. a7 248a, to make Fed services more widely available.

A ‘bank account for banks’

According to the opinion, Custodia is a special purpose depository institution, or SPDI, a novel bank charter Wyoming created in 2019 to serve digital asset companies. SPDIs are generally prohibited from making loans and must maintain 100% reserves for their deposits.

Custodia applied for a master account with the Kansas City Fed in October 2020, the opinion says. A master account is a “bank account for banks” that allows direct access to the Federal Reserve’s payment systems, including wire transfers and settlement services. Without it, a bank must partner with an intermediary correspondent bank, according to the opinion.

In denying the application in January 2023, the Kansas City Fed said Custodia’s “novel and unprecedented” crypto-focused business model presented “heightened risks” that were “inconsistent with safe and sound banking practices,” the opinion says.

Custodia sued the Kansas City Fed and the Federal Reserve Board of Governors in the U.S. District Court for the District of Wyoming in June 2022.

U.S. District Judge Scott W. Skavdahl granted summary judgment to the Fed, concluding that the relevant statutes give reserve banks discretion. Custodia Bank Inc. v. Fed. Reserve Bd. of Governors, 728 F. Supp. 3d 1227 (D. Wyo. 2024).

Custodia appealed.

Categories
News

Big Tech Docket: ChatGPT summaries and outlines may infringe copyrights

(Westlaw) A federal judge has green-lighted authors’ copyright claims against OpenAI, and a university says Google Earth violates its patent rights. Here’s a roundup of recent events in the world of Big Tech.

Artificial intelligence

A class of authors can proceed with direct copyright infringement claims against OpenAI Inc. alleging that outputs from its ChatGPT model are “substantially similar” to their books, Reuters reports. In an Oct. 27 ruling, U.S. District Judge Sidney H. Stein of the Southern District of New York denied OpenAI’s motion to dismiss the authors’ claims that detailed summaries and outlines for potential sequels produced by ChatGPT are infringing derivative works. In re OpenAI Inc. Copyright Infringement Litigation, No. 25-md-3143, 2025 WL 3003339 (S.D.N.Y. Oct. 27, 2025).

A California federal judge dismissed a trademark lawsuit against Perplexity AI Inc. Oct. 27 after the plaintiff’s attorneys withdrew in August and were not replaced, Reuters reports. Software company Perplexity Solved Solutions Inc. received a federal trademark for “Perplexity” in 2022 and had claimed that Perplexity AI’s name would confuse consumers. Perplexity Solved Solutions Inc. v. Perplexity AI Inc., No. 25-cv-989, 2025 WL 3004044 (N.D. Cal. Oct. 27, 2025).

Antitrust

Software giant SAP SE must face an antitrust lawsuit by competitor Celonis SE accusing it of monopolizing a segment of the business software market, Reuters reports. A California federal judge ruled Oct. 27 that Celonis had presented enough information to pursue antitrust, unfair competition and false advertising allegations against SAP, but dismissed a claim that SAP was illegally “tying” the sale of one product to another. Celonis SE et al. v. SAP SE et al., 2025 WL 3013158, No. 25-cv-2519 (N.D. Cal. Oct. 27, 2025).

Intellectual property

Apple Inc. has asked a federal judge in Georgia to dismiss a racketeering lawsuit by Fintiv Inc. alleging that the iPhone maker misappropriated its technology to create the Apple Pay mobile wallet, Reuters reports. Apple argues that Fintiv waited too long to pursue its claims and failed to show a pattern of racketeering. Fintiv Inc. v. Apple Inc., No. 25-4413, motion filed (N.D. Ga. Oct. 27, 2025).

The University of Southern California says in an Oct. 27 federal complaint that Google LLC’s Earth, maps and street view applications violate its patent rights, Reuters reports. USC says Google had known for years about technology one of its professors developed integrating two-dimensional images into three-dimensional models. University of Southern California v. Google LLC, No. 25-cv-1734, complaint filed (W.D. Tex. Oct. 27, 2025).

Social media

The European Commission announced in an Oct. 24 press statement that Meta Platforms Inc. and TikTok have breached their obligation under the EU’s Digital Services Act to grant researchers adequate access to public data. The commission also announced that Meta has breached its obligations to provide users of Facebook and Instagram with simple ways to flag illegal content and challenge content moderation decisions. If the findings are upheld, the tech giants may face fines of up to 6% of global annual turnover.

Categories
News

Pfizer accuses Novo Nordisk of anticompetitive plot to stall Metsera deal in lawsuit

(Reuters) – Pfizer filed a second lawsuit on Monday accusing Danish drugmaker Novo Nordisk of structuring its $9 billion bid for biotech Metsera to stall, not close, the deal, a tactic it said is designed to suppress competition in obesity drugs.

Novo and Metsera on Monday rejected Pfizer’s claims, in a dramatic escalation in the legal and bidding fight for control of the biotech startup, which is developing next-generation obesity drugs. A judge will analyze the complaints on Tuesday.

Pfizer agreed to pay up to $7.3 billion for Metsera in September, after a private bidding war with Novo for the biotech firm that lasted months. Metsera said Novo already had a big chunk of the market, could face antitrust scrutiny, and rejected Novo’s offer six times.

But last week, after Novo’s top investor overhauled the board, the Danish company launched an unsolicited rival bid – its seventh since January.

In a surprising move, Metsera said Novo’s offer was superior and gave Pfizer until Tuesday to submit a higher bid.

That prompted Pfizer to sue Metsera’s board and Novo in Delaware’s Court of Chancery on Friday and then it hit Novo with an antitrust lawsuit in Delaware federal court on Monday.

The state court case was assigned to Vice Chancellor Morgan Zurn, who scheduled a hearing for Tuesday morning.

Metsera accused Pfizer of gaming the schedule by not suing sooner, when it knew of Novo’s bid on October 25, and of trying to drive down its takeover price. The company in a statement described Pfizer’s allegations as “nonsense,” adding that it will respond to the claims in court.

Novo on Monday said it closely adhered to all of the restrictions under the Pfizer merger agreement.

“We are confident that the facts and the law are on our side,” Novo said in a statement. “Pfizer’s suggestion that Novo Nordisk would impair or potentially stop an emerging US competitor is absurd and not based on facts, common sense, or market realities.”

Metsera is developing a new obesity drug that would have the benefit of monthly injections versus weekly injections required for wildly popular Wegovy from Novo and Eli Lilly’s Zepbound and Mounjaro.

Pfizer is betting on Metsera to help it enter an obesity market some analysts forecast could soon reach $150 billion annually.

Metsera is working on experimental therapies analysts say could generate $5 billion in sales.

PFIZER SAYS NOVO AIMS TO DELAY COMPETITION

Pfizer’s second complaint, filed in U.S. District Court in Delaware on Monday, alleges Novo Nordisk is using a 30-month “outside date” the period before either party can terminate the merger to delay Metsera’s entry into the market for obesity drugs that target the GLP-1 protein, currently dominated by Novo and Lilly.

Pfizer said its own deal with Metsera had a nine-month timeline and received early termination of antitrust review on October 31.

Pfizer claims Novo Nordisk’s bid is not a genuine acquisition attempt but a strategic maneuver to block Metsera from advancing its drugs in development and preserve Wegovy and Ozempic’s market share.

In the suit, Novo is accused of offering Metsera shareholders $6.5 billion upfront before regulatory review and tying the company to restrictive covenants that delay or prevent clinical progress.

“Something is clearly rotten in the state of Denmark,” Pfizer wrote in its complaint a pointed reference to Shakespeare’s Hamlet that underscores the company’s view of Novo’s motives following a recent board purge by its controlling shareholder.

Metsera shares fell 3.7% on Monday to close at $60.73. Pfizer shares ended flat, while Novo shares fell less than 1%.